Solution
Livers Inc. | ||
Statement of Cash Flows | ||
For the Year Ended December 31, 20Y3 | ||
A. Cash Flows from Operating Activity | ||
Net Income | $ 63,250 | |
Adjustments to reconcile net income to net cash flow from operating activities: | ||
Depreciation expense | $ 6,860 | |
Gain on sale of Investment | -$ 16,470 | |
Changes in current operating assets and liabilities: | ||
Increase in Accounts Receivables | -$ 6,700 | |
Increase in Inventory | -$ 7,280 | |
Increase in Accounts Payable | $ 8,760 | |
Decrease in Accrued expenses | -$ 4,440 | |
Net cash flow from Operating activities | $ 43,980 | |
B. Cash flows from Investing Activities | ||
Cash received from Sale of Investment | $ 113,360 | |
Cash paid for Purchase of Land | -$ 1,32,000 | |
Cash paid for Purchase of Equipment | -$ 62,850 | |
Net Cash flows from Investing activities | -$ 81,490 | |
C. Cash Flows from Financing activities | ||
Cash received from sale of Common stock | $ 90,860 | |
Cash paid for dividends | -$ 36,870 | |
Cash flows from Financing activities | $ 53,990 | |
Net Increase (Decrease) in Cash [A+B+C] | $ 16,480 | |
Cash at the beginning | $ 235,180 | |
Cash at the end | $ 251,660 |
Working
Calculation of Cash Dividend paid | |
Opening Balance of Dividends Payable | $ 7,450 |
Add: Dividends Declared during the year | $ 38,920 |
Total Dividend Liability | $ 46,370 |
Less: Closing Balance of Dividends | $ 9,500 |
Dividends Paid in cash During the year | $ 36,870 |
.General notes for cash flow
Cash is increased when Current liability increase or Current asset
Decrease.
Cash is Decreased when Current liability Decrease or Current asset
Increase.
Depreciation or loss on sale of any asset is a non cash expense
hence it will be added to net income to get operating cash
Profit on sale of asset or investment is a non cash profit and
hence will be deducted from operating income.
Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31, 2013...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $261,120 $243,460 Accounts receivable (net) 94,590 87,440 Inventories 267,040 258,890 Investments 0 100,300 Land 136,970 0 Equipment 294,620 228,890 Accumulated depreciation—equipment (68,980) (61,720) Total assets $985,360 $857,260 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $178,350 $168,880 Accrued expenses payable (operating expenses) 17,740 22,290 Dividends payable 9,850 7,720 Common stock,...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $261,120 $243,460 Accounts receivable (net) 94,590 87,440 Inventories 267,040 258,890 Investments 0 100,300 Land 136,970 0 Equipment 294,620 228,890 Accumulated depreciation—equipment (68,980) (61,720) Total assets $985,360 $857,260 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $178,350 $168,880 Accrued expenses payable (operating expenses) 17,740 22,290 Dividends payable 9,850 7,720 Common stock,...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $253,630 $237,840 Accounts receivable (net) 91,880 85,420 Inventories 259,370 252,910 Investments 0 97,980 Land 133,030 0 Equipment 286,170 223,600 Accumulated depreciation—equipment (67,000) (60,300) Total assets $957,080 $837,450 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $173,230 $164,980 Accrued expenses payable (operating expenses) 17,230 21,770 Dividends payable 9,570 7,540 Common stock,...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $244,600 $230,160 Accounts receivable (net) 88,610 82,660 Inventories 250,140 244,740 Investments 0 94,820 Land 128,300 0 Equipment 275,980 216,380 Accumulated depreciation—equipment (64,610) (58,350) Total assets $923,020 $810,410 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $167,070 $159,650 Accrued expenses payable (operating expenses) 16,610 21,070 Dividends payable 9,230 7,290 Common stock,...
he comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $270,970 $250,900 Accounts receivable (net) 98,160 90,110 Inventories 277,110 266,820 Investments 0 103,360 Land 142,130 0 Equipment 305,730 235,880 Accumulated depreciation—equipment (71,580) (63,610) Total assets $1,022,520 $883,460 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $185,080 $174,040 Accrued expenses payable (operating expenses) 18,410 22,970 Dividends payable 10,230 7,950 Common stock, $10 par 55,220 43,290 Paid-in...
Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets 3 Cash $626,640.00 $585,760.00 Accounts receivable (net) 226,900.00 208,390.00 Inventories 641,350.00 616,130.00 Investments 0.00 239,300.00 Land 328,730.00 0.00 Equipment 705,940.00 Accumulated depreciation-equipment (166,970.00) 553,530.00 (148,000.00) $2,055,110.00 Total assets $2,362,590.00 Liabilities and Stockholders' Equity 12 Accounts payable (merchandise creditors) $425,140.00 $404,540.00 13 Accrued expenses payable (operating expenses) 42,020.00 52,750.00 Dividends payable 23,580.00 19,500.00 Common stock, $4...
Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $260,120 $240,850 Accounts receivable (net) 94,230 86,500 Inventories 266,000 256,120 Investments 0 99,230 Land 136,440 0 Equipment 293,490 226,440 Accumulated depreciation-equipment (68,710) (61,060) Total assets $981,570 $848,080 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $177,660 $167,070 Accrued expenses payable (operating expenses) 17,670 22,050 Dividends payable 9,820 7,630 Common stock,...
statement of Cash Flows-Indirect Method The comparative balance sheet of Olson-Jones Industries Inc. for December 31, 2012 and 2041, is as follows: Dec. 31, Dec. 31, 2011 Assets 2012 Cash $145 Accounts receivable (net) Inventories Land Equipment Accumulated depreciation equipment (18) Total Assets Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) Dividends payable Common stock, $1 par Paid in capital: Excess of issue price over par- common stock Retained earnings Total liabilities and stockholders equity Total liabilities and stockholders' equity...
Statement of Cash Flows-Indirect Method The comparative balance sheet of Olson-Jones Industries Inc. for December 31, 2012 and 2041, is as follows: Dec. 31, 2012 Dec. 31, 20Y1 Assets Cash Accounts receivable (net) Inventories Land Equipment 175 (42) Accumulated depreciation-equipment Total assets $625 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) Dividends payable Common stock, $1 par Pald-in capital: Excess of issue price over par- common stock Retained earnings Total liabilities and stockholders' equity 742 5625 The following additional information...
Statement of Cash Flows-Indirect Method The comparative balance sheet of Olson-Jones Industries Inc. for December 31, 20Y2 and 2041, is as follows: Dec. 31, 20Y2 Dec. 31, 20Y1 Assets Cash $128 Accounts receivable (net) Inventories Land Equipment Accumulated depreciation-equipment (16) Total Assets $395 $269 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) Dividends payable Common stock, $1 par Paid-in capital: Excess of issue price over par- common stock Retained earnings 244 Total liabilities and stockholders' equity $395 The following additional...